Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mutation | 111 | 2024 | 30016 | 2.130 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 24 | 2023 | 1639 | 2.030 |
Why?
|
Genome, Human | 40 | 2021 | 4421 | 1.670 |
Why?
|
Neoplasms | 48 | 2023 | 22131 | 1.580 |
Why?
|
High-Throughput Nucleotide Sequencing | 26 | 2022 | 3634 | 1.540 |
Why?
|
DNA Mutational Analysis | 24 | 2020 | 4110 | 1.450 |
Why?
|
Genes, Neoplasm | 8 | 2018 | 370 | 1.450 |
Why?
|
Genomics | 38 | 2023 | 5822 | 1.350 |
Why?
|
Sequence Analysis, DNA | 28 | 2020 | 4739 | 1.300 |
Why?
|
Multiple Myeloma | 17 | 2024 | 5146 | 1.260 |
Why?
|
Software | 11 | 2022 | 4431 | 1.100 |
Why?
|
Sequence Analysis, RNA | 12 | 2022 | 2014 | 1.020 |
Why?
|
Drug Resistance, Neoplasm | 30 | 2023 | 5304 | 0.930 |
Why?
|
DNA Damage | 8 | 2020 | 2446 | 0.910 |
Why?
|
Gene Expression Regulation, Neoplastic | 36 | 2024 | 8542 | 0.890 |
Why?
|
DNA Copy Number Variations | 26 | 2022 | 2020 | 0.840 |
Why?
|
Microsatellite Repeats | 4 | 2019 | 783 | 0.780 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 10 | 2023 | 1405 | 0.780 |
Why?
|
Mutagenesis | 6 | 2020 | 1230 | 0.770 |
Why?
|
Gene Dosage | 14 | 2020 | 1217 | 0.760 |
Why?
|
INDEL Mutation | 3 | 2020 | 265 | 0.720 |
Why?
|
Lung Neoplasms | 25 | 2024 | 13382 | 0.700 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 3 | 2020 | 106 | 0.680 |
Why?
|
Melanoma | 17 | 2023 | 5697 | 0.640 |
Why?
|
DNA Polymerase II | 2 | 2018 | 104 | 0.640 |
Why?
|
Artifacts | 3 | 2018 | 1910 | 0.620 |
Why?
|
Oncogenes | 9 | 2022 | 1221 | 0.620 |
Why?
|
DNA, Neoplasm | 7 | 2019 | 1743 | 0.620 |
Why?
|
Point Mutation | 8 | 2017 | 1595 | 0.610 |
Why?
|
DNA Polymerase III | 1 | 2018 | 51 | 0.600 |
Why?
|
Databases, Genetic | 10 | 2020 | 1742 | 0.590 |
Why?
|
Oncogene Proteins | 4 | 2020 | 718 | 0.580 |
Why?
|
Genetic Heterogeneity | 7 | 2019 | 733 | 0.560 |
Why?
|
Humans | 234 | 2024 | 760617 | 0.520 |
Why?
|
Neoplastic Cells, Circulating | 6 | 2023 | 943 | 0.510 |
Why?
|
Carcinoma, Squamous Cell | 10 | 2023 | 4020 | 0.500 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 3 | 2022 | 179 | 0.490 |
Why?
|
DNA Mismatch Repair | 1 | 2018 | 428 | 0.480 |
Why?
|
Adenocarcinoma | 16 | 2023 | 6340 | 0.480 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2020 | 2223 | 0.470 |
Why?
|
DNA Repair | 7 | 2020 | 2043 | 0.470 |
Why?
|
Cell Line, Tumor | 40 | 2024 | 16967 | 0.460 |
Why?
|
Protein Kinase Inhibitors | 20 | 2023 | 5672 | 0.460 |
Why?
|
RNA | 3 | 2022 | 2713 | 0.460 |
Why?
|
Models, Genetic | 6 | 2019 | 3431 | 0.450 |
Why?
|
Germ-Line Mutation | 9 | 2024 | 1852 | 0.450 |
Why?
|
Breast Neoplasms | 14 | 2024 | 20988 | 0.440 |
Why?
|
Chromosome Aberrations | 10 | 2018 | 1768 | 0.420 |
Why?
|
Evolution, Molecular | 7 | 2019 | 1880 | 0.410 |
Why?
|
Tumor Suppressor Protein p53 | 15 | 2020 | 2917 | 0.410 |
Why?
|
Proto-Oncogene Proteins B-raf | 11 | 2023 | 2057 | 0.400 |
Why?
|
Mutation, Missense | 5 | 2016 | 2570 | 0.400 |
Why?
|
Gene Expression Profiling | 22 | 2022 | 9417 | 0.400 |
Why?
|
DNA, Mitochondrial | 3 | 2024 | 865 | 0.390 |
Why?
|
Gene Amplification | 9 | 2016 | 1087 | 0.390 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2024 | 5319 | 0.380 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 3 | 2019 | 214 | 0.370 |
Why?
|
Quality Control | 3 | 2021 | 831 | 0.370 |
Why?
|
Antigens, Neoplasm | 8 | 2021 | 1985 | 0.350 |
Why?
|
MAP Kinase Signaling System | 5 | 2021 | 1483 | 0.350 |
Why?
|
Clone Cells | 8 | 2021 | 1657 | 0.350 |
Why?
|
Phosphatidylinositol 3-Kinases | 10 | 2024 | 2864 | 0.350 |
Why?
|
Tumor Suppressor Proteins | 5 | 2018 | 2801 | 0.340 |
Why?
|
Genetic Techniques | 1 | 2012 | 428 | 0.330 |
Why?
|
Molecular Targeted Therapy | 9 | 2023 | 2812 | 0.320 |
Why?
|
Endometrial Neoplasms | 4 | 2018 | 1365 | 0.320 |
Why?
|
Genomic Instability | 6 | 2023 | 709 | 0.320 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1453 | 0.310 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2022 | 2821 | 0.310 |
Why?
|
Cytidine Deaminase | 2 | 2023 | 243 | 0.300 |
Why?
|
Glioblastoma | 6 | 2023 | 3481 | 0.290 |
Why?
|
Promoter Regions, Genetic | 3 | 2018 | 5780 | 0.290 |
Why?
|
Genetic Predisposition to Disease | 18 | 2024 | 17878 | 0.290 |
Why?
|
Antineoplastic Agents | 16 | 2023 | 13635 | 0.290 |
Why?
|
Disease Progression | 17 | 2023 | 13495 | 0.290 |
Why?
|
Computational Biology | 8 | 2017 | 3509 | 0.280 |
Why?
|
Consensus Sequence | 1 | 2007 | 364 | 0.280 |
Why?
|
Neoplasm Proteins | 7 | 2021 | 3607 | 0.280 |
Why?
|
Precancerous Conditions | 2 | 2023 | 980 | 0.270 |
Why?
|
Genetic Variation | 7 | 2018 | 6561 | 0.260 |
Why?
|
Barrett Esophagus | 2 | 2023 | 492 | 0.260 |
Why?
|
Genes, Tumor Suppressor | 4 | 2019 | 1056 | 0.260 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2016 | 476 | 0.250 |
Why?
|
DNA | 4 | 2019 | 7196 | 0.250 |
Why?
|
Single-Cell Analysis | 7 | 2024 | 2447 | 0.240 |
Why?
|
Brain Neoplasms | 8 | 2020 | 9026 | 0.240 |
Why?
|
Colorectal Neoplasms | 6 | 2023 | 6925 | 0.240 |
Why?
|
DNA Replication | 3 | 2018 | 1414 | 0.240 |
Why?
|
Neoplasm Metastasis | 11 | 2019 | 4910 | 0.240 |
Why?
|
Microsatellite Instability | 2 | 2019 | 716 | 0.240 |
Why?
|
Dual Specificity Phosphatase 6 | 2 | 2021 | 13 | 0.240 |
Why?
|
Genome-Wide Association Study | 16 | 2022 | 12661 | 0.230 |
Why?
|
Lactams, Macrocyclic | 2 | 2016 | 318 | 0.230 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 6 | 2024 | 899 | 0.230 |
Why?
|
Cell Proliferation | 14 | 2022 | 10432 | 0.230 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 2 | 2016 | 170 | 0.220 |
Why?
|
Esophageal Neoplasms | 3 | 2023 | 1653 | 0.220 |
Why?
|
Plasma Cells | 3 | 2022 | 597 | 0.220 |
Why?
|
Cluster Analysis | 8 | 2021 | 2700 | 0.210 |
Why?
|
Female | 71 | 2024 | 392148 | 0.210 |
Why?
|
Gene Regulatory Networks | 5 | 2018 | 1745 | 0.210 |
Why?
|
Transplantation, Autologous | 3 | 2023 | 2112 | 0.210 |
Why?
|
Liposarcoma | 2 | 2019 | 289 | 0.210 |
Why?
|
Cholangiocarcinoma | 2 | 2019 | 552 | 0.200 |
Why?
|
Alleles | 7 | 2018 | 6861 | 0.200 |
Why?
|
DNA Methylation | 6 | 2020 | 4391 | 0.200 |
Why?
|
Tumor Microenvironment | 9 | 2023 | 3868 | 0.200 |
Why?
|
Phosphoproteins | 4 | 2020 | 2446 | 0.200 |
Why?
|
Sample Size | 3 | 2016 | 838 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5672 | 0.200 |
Why?
|
Craniopharyngioma | 2 | 2015 | 276 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2021 | 47 | 0.200 |
Why?
|
Neoplasms, Squamous Cell | 2 | 2013 | 95 | 0.200 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2021 | 71 | 0.190 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2023 | 11736 | 0.190 |
Why?
|
Cohort Studies | 17 | 2022 | 41457 | 0.190 |
Why?
|
Cancer Vaccines | 3 | 2018 | 1037 | 0.190 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2018 | 569 | 0.190 |
Why?
|
Algorithms | 12 | 2022 | 14018 | 0.190 |
Why?
|
Translocation, Genetic | 4 | 2016 | 1392 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2022 | 9277 | 0.190 |
Why?
|
Immunoglobulin Variable Region | 1 | 2022 | 419 | 0.190 |
Why?
|
Mosaicism | 1 | 2024 | 474 | 0.190 |
Why?
|
Base Sequence | 11 | 2023 | 12421 | 0.180 |
Why?
|
Carcinoma | 3 | 2019 | 2327 | 0.180 |
Why?
|
Tachykinins | 1 | 2021 | 77 | 0.180 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2024 | 1348 | 0.180 |
Why?
|
Antibodies, Bispecific | 1 | 2023 | 196 | 0.180 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 56 | 0.180 |
Why?
|
Osteosarcoma | 2 | 2018 | 896 | 0.180 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2024 | 592 | 0.180 |
Why?
|
Male | 61 | 2024 | 360358 | 0.180 |
Why?
|
Organ Specificity | 3 | 2022 | 1964 | 0.170 |
Why?
|
Genes, p53 | 2 | 2012 | 712 | 0.170 |
Why?
|
Repressor Proteins | 3 | 2021 | 2985 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2023 | 1404 | 0.170 |
Why?
|
False Positive Reactions | 2 | 2013 | 957 | 0.170 |
Why?
|
Protein Structure, Tertiary | 7 | 2015 | 3792 | 0.170 |
Why?
|
Reed-Sternberg Cells | 1 | 2019 | 72 | 0.170 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2017 | 937 | 0.170 |
Why?
|
Prenylation | 1 | 2019 | 37 | 0.170 |
Why?
|
Gene Deletion | 3 | 2019 | 2661 | 0.170 |
Why?
|
Bone Neoplasms | 3 | 2018 | 2527 | 0.170 |
Why?
|
Immunotherapy | 5 | 2023 | 4642 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 283 | 0.170 |
Why?
|
Genetic Loci | 3 | 2018 | 2624 | 0.170 |
Why?
|
Apyrase | 2 | 2019 | 373 | 0.170 |
Why?
|
Signal Transduction | 21 | 2021 | 23416 | 0.170 |
Why?
|
Glioma | 4 | 2018 | 3453 | 0.170 |
Why?
|
Paraproteinemias | 1 | 2022 | 248 | 0.160 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2020 | 1608 | 0.160 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 401 | 0.160 |
Why?
|
Chromosome Deletion | 5 | 2016 | 1386 | 0.160 |
Why?
|
E2F Transcription Factors | 2 | 2017 | 269 | 0.160 |
Why?
|
RNA Splicing | 4 | 2021 | 898 | 0.160 |
Why?
|
Multigene Family | 3 | 2018 | 1076 | 0.160 |
Why?
|
Lipogenesis | 1 | 2020 | 214 | 0.160 |
Why?
|
Receptors, Aryl Hydrocarbon | 2 | 2019 | 220 | 0.160 |
Why?
|
Head and Neck Neoplasms | 3 | 2023 | 2894 | 0.160 |
Why?
|
Contact Inhibition | 1 | 2018 | 46 | 0.160 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2016 | 1626 | 0.150 |
Why?
|
Pyrimidines | 7 | 2023 | 3027 | 0.150 |
Why?
|
Kynurenine | 1 | 2019 | 141 | 0.150 |
Why?
|
Transplantation, Homologous | 2 | 2024 | 4804 | 0.150 |
Why?
|
Protein Binding | 5 | 2021 | 9345 | 0.150 |
Why?
|
B-Lymphocytes | 5 | 2023 | 4745 | 0.150 |
Why?
|
Poisson Distribution | 1 | 2019 | 504 | 0.150 |
Why?
|
Bayes Theorem | 4 | 2018 | 2326 | 0.150 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1394 | 0.150 |
Why?
|
Retinoblastoma Protein | 3 | 2020 | 671 | 0.150 |
Why?
|
Estrogen Receptor alpha | 2 | 2020 | 583 | 0.150 |
Why?
|
Cyclin E | 2 | 2020 | 155 | 0.150 |
Why?
|
Mitochondria | 3 | 2020 | 3619 | 0.150 |
Why?
|
DNA-Binding Proteins | 9 | 2020 | 9586 | 0.150 |
Why?
|
Ploidies | 3 | 2013 | 285 | 0.150 |
Why?
|
Genomic Structural Variation | 1 | 2018 | 68 | 0.150 |
Why?
|
Camptothecin | 1 | 2021 | 591 | 0.150 |
Why?
|
Neoplasms, Experimental | 3 | 2019 | 1226 | 0.150 |
Why?
|
Computer Graphics | 1 | 2019 | 340 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 250 | 0.150 |
Why?
|
Gene Rearrangement | 7 | 2018 | 1125 | 0.150 |
Why?
|
Bone Marrow | 3 | 2023 | 2909 | 0.150 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2019 | 1727 | 0.150 |
Why?
|
Phenotype | 13 | 2023 | 16571 | 0.140 |
Why?
|
Ovarian Neoplasms | 5 | 2014 | 4849 | 0.140 |
Why?
|
Alternative Splicing | 3 | 2019 | 1088 | 0.140 |
Why?
|
Quinazolines | 3 | 2016 | 1371 | 0.140 |
Why?
|
Dog Diseases | 1 | 2018 | 141 | 0.140 |
Why?
|
Dogs | 3 | 2018 | 3838 | 0.140 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.140 |
Why?
|
Neoplasm, Residual | 2 | 2020 | 1008 | 0.140 |
Why?
|
Phenylurea Compounds | 2 | 2019 | 529 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2017 | 164 | 0.140 |
Why?
|
Hematopoiesis | 3 | 2021 | 2049 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2016 | 106 | 0.140 |
Why?
|
Nuclear Proteins | 5 | 2021 | 5789 | 0.140 |
Why?
|
Models, Molecular | 7 | 2016 | 5433 | 0.140 |
Why?
|
CA-125 Antigen | 1 | 2019 | 276 | 0.140 |
Why?
|
Middle Aged | 39 | 2024 | 220584 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 3 | 2015 | 410 | 0.140 |
Why?
|
Disease | 1 | 2022 | 670 | 0.140 |
Why?
|
Prostate-Specific Antigen | 3 | 2021 | 2465 | 0.140 |
Why?
|
Chromatin | 5 | 2021 | 2955 | 0.130 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10175 | 0.130 |
Why?
|
MicroRNAs | 6 | 2019 | 3805 | 0.130 |
Why?
|
beta Catenin | 4 | 2014 | 1039 | 0.130 |
Why?
|
Catalytic Domain | 2 | 2015 | 704 | 0.130 |
Why?
|
Genes, X-Linked | 1 | 2016 | 128 | 0.130 |
Why?
|
Pituitary Neoplasms | 2 | 2015 | 1323 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2019 | 1745 | 0.130 |
Why?
|
Astrocytoma | 1 | 2020 | 774 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2018 | 682 | 0.130 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 544 | 0.130 |
Why?
|
Aged, 80 and over | 19 | 2022 | 58894 | 0.130 |
Why?
|
Sulfonamides | 4 | 2019 | 1977 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2057 | 0.130 |
Why?
|
Prognosis | 10 | 2022 | 29600 | 0.130 |
Why?
|
Reproducibility of Results | 8 | 2021 | 20074 | 0.130 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 97 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1372 | 0.130 |
Why?
|
Transcription, Genetic | 4 | 2018 | 7583 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2191 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1971 | 0.120 |
Why?
|
Cell Cycle Proteins | 6 | 2016 | 3447 | 0.120 |
Why?
|
Genes, p16 | 2 | 2012 | 160 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 797 | 0.120 |
Why?
|
Adult | 36 | 2024 | 220969 | 0.120 |
Why?
|
Leiomyosarcoma | 1 | 2019 | 422 | 0.120 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 76 | 0.120 |
Why?
|
Stem Cell Transplantation | 1 | 2023 | 1600 | 0.120 |
Why?
|
GTPase-Activating Proteins | 1 | 2018 | 471 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1963 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1614 | 0.120 |
Why?
|
Exons | 5 | 2012 | 2381 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2014 | 3777 | 0.120 |
Why?
|
Oligodendroglioma | 1 | 2016 | 278 | 0.120 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2016 | 418 | 0.120 |
Why?
|
Immune Evasion | 2 | 2019 | 363 | 0.120 |
Why?
|
Angiomyolipoma | 1 | 2016 | 187 | 0.120 |
Why?
|
Selection, Genetic | 1 | 2019 | 868 | 0.120 |
Why?
|
Loss of Heterozygosity | 5 | 2017 | 662 | 0.120 |
Why?
|
Antigen Presentation | 2 | 2017 | 1250 | 0.120 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 321 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 287 | 0.120 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 227 | 0.120 |
Why?
|
Phosphorylation | 7 | 2023 | 8311 | 0.120 |
Why?
|
Aged | 30 | 2024 | 169042 | 0.120 |
Why?
|
Pulmonary Blastoma | 1 | 2014 | 41 | 0.120 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2016 | 201 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 247 | 0.120 |
Why?
|
Papillomavirus Infections | 3 | 2023 | 1611 | 0.110 |
Why?
|
Genes, BRCA2 | 1 | 2017 | 590 | 0.110 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 1551 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 2 | 2014 | 384 | 0.110 |
Why?
|
Oligodendroglia | 1 | 2018 | 538 | 0.110 |
Why?
|
Uveal Neoplasms | 1 | 2017 | 341 | 0.110 |
Why?
|
Kidney Neoplasms | 2 | 2024 | 4250 | 0.110 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 184 | 0.110 |
Why?
|
Immunoconjugates | 1 | 2021 | 951 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 4 | 2023 | 638 | 0.110 |
Why?
|
Prostatic Neoplasms | 5 | 2021 | 11106 | 0.110 |
Why?
|
Genes, BRCA1 | 1 | 2017 | 753 | 0.110 |
Why?
|
Pyrazoles | 4 | 2019 | 2008 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1149 | 0.110 |
Why?
|
DNA Replication Timing | 1 | 2013 | 34 | 0.110 |
Why?
|
Receptors, Estrogen | 2 | 2022 | 2208 | 0.110 |
Why?
|
Apoptosis | 8 | 2019 | 9476 | 0.110 |
Why?
|
Receptor, erbB-2 | 4 | 2022 | 2553 | 0.110 |
Why?
|
Databases, Protein | 1 | 2015 | 387 | 0.110 |
Why?
|
Tongue Neoplasms | 1 | 2015 | 183 | 0.110 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2018 | 655 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2014 | 717 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2022 | 2894 | 0.110 |
Why?
|
Biological Products | 1 | 2022 | 912 | 0.110 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 2332 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2013 | 184 | 0.110 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2018 | 368 | 0.110 |
Why?
|
Polyploidy | 1 | 2013 | 119 | 0.110 |
Why?
|
RNA, Messenger | 3 | 2017 | 12758 | 0.110 |
Why?
|
Tumor Burden | 1 | 2019 | 1892 | 0.110 |
Why?
|
Retroelements | 1 | 2014 | 162 | 0.110 |
Why?
|
Testicular Neoplasms | 2 | 2016 | 800 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2018 | 15908 | 0.100 |
Why?
|
Animals | 29 | 2023 | 168201 | 0.100 |
Why?
|
Anus Neoplasms | 1 | 2016 | 329 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1988 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3836 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 319 | 0.100 |
Why?
|
Sirtuins | 1 | 2015 | 319 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2015 | 656 | 0.100 |
Why?
|
Epigenesis, Genetic | 5 | 2022 | 3794 | 0.100 |
Why?
|
Androgen Antagonists | 1 | 2021 | 1409 | 0.100 |
Why?
|
Gene Library | 2 | 2012 | 1055 | 0.100 |
Why?
|
Computer Simulation | 3 | 2018 | 6233 | 0.100 |
Why?
|
Encyclopedias as Topic | 1 | 2012 | 19 | 0.100 |
Why?
|
Urothelium | 1 | 2014 | 269 | 0.100 |
Why?
|
Genomic Library | 1 | 2012 | 189 | 0.100 |
Why?
|
Transcription Factors | 9 | 2021 | 12116 | 0.100 |
Why?
|
Ribonuclease III | 1 | 2014 | 279 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 782 | 0.100 |
Why?
|
Cisplatin | 2 | 2017 | 1650 | 0.100 |
Why?
|
Cell Survival | 8 | 2016 | 5780 | 0.100 |
Why?
|
Protein Biosynthesis | 2 | 2017 | 2100 | 0.100 |
Why?
|
Receptors, Androgen | 1 | 2018 | 1079 | 0.100 |
Why?
|
Neoplastic Stem Cells | 2 | 2017 | 1350 | 0.100 |
Why?
|
Qb-SNARE Proteins | 1 | 2011 | 34 | 0.100 |
Why?
|
Protein Interaction Mapping | 1 | 2015 | 615 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 955 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2021 | 2456 | 0.100 |
Why?
|
Antigens, CD | 2 | 2019 | 3998 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3575 | 0.100 |
Why?
|
Guanine | 1 | 2013 | 278 | 0.100 |
Why?
|
Aneuploidy | 2 | 2012 | 552 | 0.100 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 491 | 0.100 |
Why?
|
Urinary Bladder | 1 | 2017 | 1151 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4571 | 0.090 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2112 | 0.090 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 360 | 0.090 |
Why?
|
Genome, Fungal | 1 | 2012 | 201 | 0.090 |
Why?
|
Spliceosomes | 1 | 2011 | 119 | 0.090 |
Why?
|
Internet | 2 | 2015 | 3090 | 0.090 |
Why?
|
Bile Duct Neoplasms | 1 | 2016 | 605 | 0.090 |
Why?
|
RNA, Ribosomal | 1 | 2012 | 227 | 0.090 |
Why?
|
Pyrimidinones | 3 | 2023 | 385 | 0.090 |
Why?
|
Cell Division | 1 | 2018 | 4457 | 0.090 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.090 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 314 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 5367 | 0.090 |
Why?
|
Gene Silencing | 1 | 2017 | 1503 | 0.090 |
Why?
|
Rhabdomyosarcoma | 1 | 2014 | 358 | 0.090 |
Why?
|
Cell Cycle | 3 | 2016 | 2930 | 0.090 |
Why?
|
Neurofibromin 1 | 1 | 2012 | 190 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2014 | 376 | 0.090 |
Why?
|
Gene Fusion | 4 | 2016 | 356 | 0.090 |
Why?
|
Genetic Markers | 3 | 2018 | 2601 | 0.090 |
Why?
|
Urologic Neoplasms | 1 | 2014 | 314 | 0.090 |
Why?
|
Ultraviolet Rays | 2 | 2012 | 1079 | 0.090 |
Why?
|
Mice | 17 | 2023 | 81368 | 0.090 |
Why?
|
Chromosome Mapping | 2 | 2016 | 4611 | 0.090 |
Why?
|
Neuroendocrine Tumors | 2 | 2013 | 641 | 0.090 |
Why?
|
Sunlight | 1 | 2012 | 337 | 0.090 |
Why?
|
Schizosaccharomyces | 1 | 2012 | 237 | 0.090 |
Why?
|
Rhabdoid Tumor | 1 | 2012 | 210 | 0.090 |
Why?
|
Biotechnology | 1 | 2012 | 281 | 0.090 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 55 | 0.090 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 423 | 0.090 |
Why?
|
Cell Separation | 2 | 2014 | 1718 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11874 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 4 | 2020 | 4512 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2013 | 790 | 0.090 |
Why?
|
Acetylation | 2 | 2023 | 1055 | 0.080 |
Why?
|
Enzyme Activation | 3 | 2021 | 3591 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 7995 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 2895 | 0.080 |
Why?
|
RNA Interference | 5 | 2019 | 2830 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 4570 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2021 | 7847 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2020 | 697 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2024 | 3164 | 0.080 |
Why?
|
Skin Neoplasms | 3 | 2013 | 5812 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 938 | 0.080 |
Why?
|
Oximes | 3 | 2015 | 303 | 0.080 |
Why?
|
Gene Expression | 4 | 2015 | 7568 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1890 | 0.080 |
Why?
|
Cells, Cultured | 7 | 2020 | 18937 | 0.080 |
Why?
|
Receptor, Notch1 | 1 | 2011 | 496 | 0.080 |
Why?
|
Pyridones | 3 | 2023 | 808 | 0.080 |
Why?
|
Trans-Activators | 2 | 2019 | 2852 | 0.080 |
Why?
|
Histones | 4 | 2023 | 2577 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3028 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2022 | 315 | 0.070 |
Why?
|
HEK293 Cells | 5 | 2014 | 4269 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2014 | 2358 | 0.070 |
Why?
|
Pyridines | 2 | 2018 | 2874 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3612 | 0.070 |
Why?
|
Cerebellar Neoplasms | 1 | 2012 | 586 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1533 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 4 | 2018 | 1113 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 915 | 0.070 |
Why?
|
Homozygote | 1 | 2012 | 1776 | 0.070 |
Why?
|
Genome, Bacterial | 1 | 2012 | 783 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1528 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2013 | 2872 | 0.070 |
Why?
|
Cell Line | 5 | 2021 | 15576 | 0.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2012 | 725 | 0.070 |
Why?
|
Medulloblastoma | 1 | 2012 | 677 | 0.070 |
Why?
|
Amino Acid Sequence | 5 | 2019 | 13441 | 0.070 |
Why?
|
Macrophages | 2 | 2019 | 5758 | 0.070 |
Why?
|
Case-Control Studies | 5 | 2019 | 22148 | 0.070 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2231 | 0.070 |
Why?
|
DNA Breaks, Double-Stranded | 2 | 2023 | 612 | 0.070 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 17629 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2018 | 3672 | 0.070 |
Why?
|
Neoadjuvant Therapy | 4 | 2021 | 2827 | 0.070 |
Why?
|
Heterozygote | 1 | 2013 | 2780 | 0.070 |
Why?
|
Genotype | 4 | 2018 | 12978 | 0.070 |
Why?
|
Cell Lineage | 3 | 2017 | 2554 | 0.060 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2007 | 361 | 0.060 |
Why?
|
Genome | 2 | 2011 | 1737 | 0.060 |
Why?
|
Databases, Nucleic Acid | 2 | 2019 | 205 | 0.060 |
Why?
|
Genes, myc | 2 | 2018 | 390 | 0.060 |
Why?
|
Mice, Nude | 4 | 2014 | 3605 | 0.060 |
Why?
|
CDC2-CDC28 Kinases | 2 | 2016 | 110 | 0.060 |
Why?
|
Lactams | 2 | 2016 | 156 | 0.060 |
Why?
|
Probability | 2 | 2007 | 2475 | 0.060 |
Why?
|
NIH 3T3 Cells | 3 | 2013 | 669 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1250 | 0.060 |
Why?
|
GTP Phosphohydrolases | 2 | 2021 | 517 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2010 | 560 | 0.060 |
Why?
|
Sequence Alignment | 3 | 2015 | 2178 | 0.060 |
Why?
|
Phylogeny | 3 | 2016 | 2806 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2013 | 1248 | 0.060 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2189 | 0.060 |
Why?
|
Gene Frequency | 3 | 2017 | 3601 | 0.060 |
Why?
|
User-Computer Interface | 2 | 2013 | 1397 | 0.060 |
Why?
|
Treatment Outcome | 10 | 2022 | 64568 | 0.060 |
Why?
|
Imidazoles | 3 | 2015 | 1175 | 0.060 |
Why?
|
Meningioma | 1 | 2013 | 1215 | 0.060 |
Why?
|
Virus Integration | 2 | 2018 | 304 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2012 | 5863 | 0.060 |
Why?
|
Immunologic Memory | 2 | 2024 | 1355 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2021 | 614 | 0.050 |
Why?
|
Chemokine CCL4 | 1 | 2023 | 126 | 0.050 |
Why?
|
Core Binding Factor beta Subunit | 2 | 2013 | 42 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9172 | 0.050 |
Why?
|
Sulfones | 2 | 2016 | 447 | 0.050 |
Why?
|
F-Box Proteins | 2 | 2015 | 201 | 0.050 |
Why?
|
Transcriptional Activation | 2 | 2022 | 1755 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2019 | 6126 | 0.050 |
Why?
|
Neoplasm Invasiveness | 3 | 2017 | 3593 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2023 | 178 | 0.050 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2015 | 332 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2012 | 3392 | 0.050 |
Why?
|
Models, Theoretical | 2 | 2011 | 3567 | 0.050 |
Why?
|
Immunotherapy, Adoptive | 2 | 2022 | 1467 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2019 | 22115 | 0.050 |
Why?
|
HLA Antigens | 2 | 2020 | 1329 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2020 | 1608 | 0.050 |
Why?
|
Aminopyridines | 2 | 2016 | 573 | 0.050 |
Why?
|
Paired Box Transcription Factors | 2 | 2014 | 206 | 0.050 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2021 | 1520 | 0.050 |
Why?
|
Chromosome Breakpoints | 2 | 2012 | 93 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1896 | 0.050 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 43 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2020 | 0.050 |
Why?
|
Protein Conformation | 3 | 2014 | 3965 | 0.050 |
Why?
|
Workflow | 2 | 2019 | 849 | 0.050 |
Why?
|
Dimerization | 2 | 2013 | 890 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2021 | 178 | 0.050 |
Why?
|
bcl-X Protein | 2 | 2015 | 410 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2013 | 373 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2015 | 1894 | 0.050 |
Why?
|
Cell Adhesion Molecules | 2 | 2021 | 1602 | 0.050 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2014 | 651 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2024 | 1349 | 0.050 |
Why?
|
raf Kinases | 2 | 2013 | 118 | 0.050 |
Why?
|
Sequence Deletion | 2 | 2018 | 1490 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 819 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12719 | 0.040 |
Why?
|
Graft vs Leukemia Effect | 1 | 2020 | 121 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2016 | 2509 | 0.040 |
Why?
|
Recurrence | 3 | 2019 | 8426 | 0.040 |
Why?
|
DNA Breaks | 1 | 2020 | 47 | 0.040 |
Why?
|
Escherichia coli | 1 | 2012 | 4209 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 629 | 0.040 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2021 | 304 | 0.040 |
Why?
|
Risk | 2 | 2022 | 9604 | 0.040 |
Why?
|
Quinazolinones | 1 | 2021 | 221 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14648 | 0.040 |
Why?
|
High-Throughput Screening Assays | 2 | 2016 | 933 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2022 | 424 | 0.040 |
Why?
|
Methylation | 2 | 2013 | 1077 | 0.040 |
Why?
|
Nucleic Acid Conformation | 2 | 2014 | 901 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 196 | 0.040 |
Why?
|
Open Reading Frames | 2 | 2014 | 813 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18221 | 0.040 |
Why?
|
Sarcoma | 1 | 2010 | 1800 | 0.040 |
Why?
|
Melanocytes | 2 | 2012 | 509 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3599 | 0.040 |
Why?
|
Automation | 1 | 2021 | 585 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 801 | 0.040 |
Why?
|
Proteome | 2 | 2020 | 1857 | 0.040 |
Why?
|
Chromosomes, Human | 2 | 2012 | 441 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 350 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 126 | 0.040 |
Why?
|
CpG Islands | 2 | 2014 | 1192 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 561 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 72 | 0.040 |
Why?
|
Young Adult | 6 | 2022 | 59179 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2019 | 370 | 0.040 |
Why?
|
Founder Effect | 1 | 2018 | 185 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 210 | 0.040 |
Why?
|
Purines | 1 | 2021 | 606 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 344 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2018 | 194 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2019 | 340 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-1 | 1 | 2017 | 31 | 0.040 |
Why?
|
Phthalazines | 1 | 2020 | 383 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 561 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2019 | 399 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2015 | 1779 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11116 | 0.040 |
Why?
|
Blotting, Western | 2 | 2016 | 5034 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 495 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2018 | 247 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2015 | 4845 | 0.040 |
Why?
|
Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.040 |
Why?
|
Cell Shape | 1 | 2018 | 369 | 0.040 |
Why?
|
Gene Duplication | 1 | 2018 | 314 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 346 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 328 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2018 | 350 | 0.030 |
Why?
|
Ubiquitination | 1 | 2021 | 1006 | 0.030 |
Why?
|
Cell Death | 1 | 2022 | 1677 | 0.030 |
Why?
|
Diploidy | 1 | 2016 | 132 | 0.030 |
Why?
|
rho-Associated Kinases | 1 | 2018 | 281 | 0.030 |
Why?
|
Databases, Factual | 1 | 2012 | 7960 | 0.030 |
Why?
|
Papillomaviridae | 2 | 2013 | 1117 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 737 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1520 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2013 | 1242 | 0.030 |
Why?
|
Chromosome Breakage | 1 | 2016 | 159 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3419 | 0.030 |
Why?
|
Child | 6 | 2023 | 80079 | 0.030 |
Why?
|
Zebrafish | 2 | 2019 | 3007 | 0.030 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2015 | 38 | 0.030 |
Why?
|
RNA Transport | 1 | 2015 | 44 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 223 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 1748 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9461 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1008 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1329 | 0.030 |
Why?
|
Muscles | 1 | 2020 | 1573 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1835 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8516 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2018 | 860 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2016 | 2734 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6762 | 0.030 |
Why?
|
Anilides | 1 | 2018 | 411 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6807 | 0.030 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2015 | 68 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2020 | 11514 | 0.030 |
Why?
|
Tissue Donors | 1 | 2024 | 2331 | 0.030 |
Why?
|
Telomere-Binding Proteins | 1 | 2015 | 119 | 0.030 |
Why?
|
Sulfites | 1 | 2014 | 83 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 871 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12142 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2016 | 478 | 0.030 |
Why?
|
Prospective Studies | 4 | 2020 | 54360 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2015 | 232 | 0.030 |
Why?
|
Valine | 1 | 2015 | 408 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 180 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 943 | 0.030 |
Why?
|
Endogenous Retroviruses | 1 | 2015 | 111 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1788 | 0.030 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2013 | 92 | 0.030 |
Why?
|
Teratoma | 1 | 2016 | 404 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3074 | 0.030 |
Why?
|
Liver Failure | 1 | 2015 | 250 | 0.030 |
Why?
|
Germ Cells | 1 | 2017 | 634 | 0.030 |
Why?
|
Protein Kinases | 1 | 2020 | 1606 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1589 | 0.030 |
Why?
|
E1A-Associated p300 Protein | 1 | 2013 | 123 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 370 | 0.030 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2014 | 191 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 744 | 0.030 |
Why?
|
Prostatectomy | 1 | 2021 | 1824 | 0.030 |
Why?
|
Binding Sites | 2 | 2015 | 6051 | 0.030 |
Why?
|
Pyrrolidinones | 1 | 2013 | 116 | 0.030 |
Why?
|
Adenine | 1 | 2019 | 985 | 0.030 |
Why?
|
Cystectomy | 1 | 2017 | 634 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 2013 | 224 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2017 | 1434 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2019 | 14389 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 386 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2014 | 210 | 0.030 |
Why?
|
Programming Languages | 1 | 2013 | 129 | 0.030 |
Why?
|
Hemoglobins | 1 | 2018 | 1524 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2013 | 317 | 0.030 |
Why?
|
Topoisomerase Inhibitors | 1 | 2012 | 19 | 0.030 |
Why?
|
Immunity | 1 | 2018 | 994 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4117 | 0.020 |
Why?
|
S Phase | 1 | 2013 | 421 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 138 | 0.020 |
Why?
|
Interleukin-3 | 1 | 2013 | 425 | 0.020 |
Why?
|
Haplotypes | 1 | 2018 | 2713 | 0.020 |
Why?
|
Risk Factors | 4 | 2022 | 74115 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2016 | 743 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4341 | 0.020 |
Why?
|
Saliva | 1 | 2016 | 828 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 473 | 0.020 |
Why?
|
Neurofibromin 2 | 1 | 2013 | 270 | 0.020 |
Why?
|
Republic of Korea | 1 | 2013 | 583 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4539 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1360 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1085 | 0.020 |
Why?
|
Vietnam | 1 | 2012 | 406 | 0.020 |
Why?
|
Indazoles | 1 | 2013 | 304 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2014 | 656 | 0.020 |
Why?
|
Molecular Structure | 1 | 2015 | 1878 | 0.020 |
Why?
|
Glycolysis | 1 | 2015 | 835 | 0.020 |
Why?
|
Pathology, Molecular | 1 | 2014 | 329 | 0.020 |
Why?
|
Dexamethasone | 1 | 2018 | 1947 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1656 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 242 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 638 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 741 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2014 | 1162 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 1034 | 0.020 |
Why?
|
Rare Diseases | 1 | 2016 | 622 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1692 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 955 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 2014 | 693 | 0.020 |
Why?
|
Alcohol Oxidoreductases | 1 | 2011 | 168 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 410 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1610 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2020 | 80566 | 0.020 |
Why?
|
Ribonucleases | 1 | 2011 | 277 | 0.020 |
Why?
|
Culture | 1 | 2014 | 623 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2014 | 825 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11069 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 627 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 2014 | 754 | 0.020 |
Why?
|
Piperidines | 1 | 2019 | 1655 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2010 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 756 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 358 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1175 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1070 | 0.020 |
Why?
|
Retroviridae | 1 | 2012 | 851 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 380 | 0.020 |
Why?
|
Piperazines | 1 | 2020 | 2521 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6188 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2546 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2015 | 1068 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6074 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2010 | 284 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4354 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2012 | 927 | 0.020 |
Why?
|
Genes, ras | 1 | 2012 | 654 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 887 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2391 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1646 | 0.020 |
Why?
|
Microfluidics | 1 | 2014 | 651 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 982 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 318 | 0.020 |
Why?
|
Child, Preschool | 3 | 2020 | 42188 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2021 | 3394 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39063 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2011 | 749 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2849 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2878 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2012 | 718 | 0.020 |
Why?
|
K562 Cells | 1 | 2010 | 641 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1357 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6174 | 0.020 |
Why?
|
Systems Integration | 1 | 2010 | 426 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2817 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 675 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 634 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 768 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3087 | 0.020 |
Why?
|
Transplantation Conditioning | 1 | 2014 | 1590 | 0.020 |
Why?
|
Intestine, Small | 1 | 2013 | 1207 | 0.020 |
Why?
|
Medical Informatics | 1 | 2014 | 732 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2008 | 277 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 997 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2007 | 286 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 851 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4172 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4237 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1662 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2008 | 257 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2913 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3514 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9529 | 0.020 |
Why?
|
Ligands | 1 | 2013 | 3268 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2011 | 1519 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1186 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10073 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6474 | 0.020 |
Why?
|
Smoking | 2 | 2013 | 9050 | 0.020 |
Why?
|
Indoles | 1 | 2013 | 1830 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1697 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12043 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2011 | 1154 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15689 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36152 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4366 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2018 | 3954 | 0.010 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2005 | 322 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3461 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20556 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6593 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6961 | 0.010 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2005 | 259 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7237 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 2802 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13347 | 0.010 |
Why?
|
NF-kappa B | 1 | 2011 | 2481 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2413 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10548 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8833 | 0.010 |
Why?
|
Cell Movement | 1 | 2012 | 5200 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2015 | 4308 | 0.010 |
Why?
|
Homeostasis | 1 | 2011 | 3321 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4242 | 0.010 |
Why?
|
Astrocytes | 1 | 2006 | 1341 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6483 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5766 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15251 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10199 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2689 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 4935 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26049 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8699 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9998 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 39913 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88234 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 5073 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36402 | 0.000 |
Why?
|
United States | 1 | 2013 | 72272 | 0.000 |
Why?
|